These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18005180)

  • 21. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.
    de Diego C; Murga MJ; Martínez-Castro P
    Genet Test; 2004; 8(3):263-7. PubMed ID: 15727249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population.
    Lin A; Yan WH; Xu HH; Zhu M; Zhou MY
    Tissue Antigens; 2007 Sep; 70(3):252-5. PubMed ID: 17661915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait.
    Garewal G; Das R; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2005 Apr; 74(4):333-6. PubMed ID: 15777346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in Tunisian population.
    Sassi R; Hmida S; Kaabi H; Hajjej A; Abid A; Abdelkefi S; Yacoub S; Maamar M; Mojaat N; Ben Hamed L; Bellali H; Dridi A; Jridi A; Midouni B; Boukef MK
    Ann Genet; 2004; 47(4):325-30. PubMed ID: 15581829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Iron in the era of molecular biology].
    Deugnier Y; Moirand R; Brissot P; David V
    Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of overt iron overload in two individuals compound heterozygotes for a 22 base pair deletion of exon 2 and the C282Y missense mutation of the HFE gene.
    Kinkely SM; Brown BD; Lyng AT; Harrison WK; Schep GN; Goddard-Hill AC; Aubrey ME; Lillicrap D; Taylor SA
    Clin Genet; 2003 Feb; 63(2):163-5. PubMed ID: 12630967
    [No Abstract]   [Full Text] [Related]  

  • 30. Characteristics of HFE C282Y homozygotes younger than age 30 years.
    Barton JC; Felitti VJ; Lee P; Beutler E
    Acta Haematol; 2004; 112(4):219-21. PubMed ID: 15564736
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of HFE C282Y and H63D in Jewish populations and clinical implications of H63D homozygosity.
    Matas M; Guix P; Castro JA; Parera M; Ramon MM; Obrador A; Picornell A
    Clin Genet; 2006 Feb; 69(2):155-62. PubMed ID: 16433696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC; Lee PL; West C; Bottomley SS
    Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HFE Mutations as risk factors in disease.
    Worwood M
    Best Pract Res Clin Haematol; 2002 Jun; 15(2):295-314. PubMed ID: 12401309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
    Lorenz M; Kletzmayr J; Huber A; Hörl WH; Sunder-Plassmann G; Födinger M
    Kidney Int; 2005 Feb; 67(2):691-7. PubMed ID: 15673318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnosis of hereditary hemochromatosis: application of a newly-developed reverse-hybridization assay in the South African population.
    Kotze MJ; de Villiers JN; Bouwens CS; Warnich L; Zaahl MG; van der Merwe S; Oberkanins C
    Clin Genet; 2004 Apr; 65(4):317-21. PubMed ID: 15025725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.